Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3D Systems | DDD | May 17, 2024 | 3.67 | -2.39 |
3M | MMM | May 17, 2024 | 105.26 | +0.38 |
4D Molecular Therapeutics | FDMT | May 17, 2024 | 25.34 | -1.17 |
51Talk Online Education Group ADR | COE | May 17, 2024 | 7.11 | -1.80 |
5E Advanced Materials | FEAM | May 17, 2024 | 1.50 | +4.17 |
60 Degrees Pharmaceuticals | SXTP | May 17, 2024 | 0.22 | +0.85 |
7-10 Yr Trsy Bear 3X Direxion | TYO | May 17, 2024 | 14.64 | +0.95 |
7-10 Yr Trsy Bull 3X Direxion | TYD | May 17, 2024 | 24.81 | -0.78 |
7-10 Yr Trsy Ishares | IEF | May 17, 2024 | 93.11 | -0.31 |
89bio | ETNB | May 17, 2024 | 8.63 | -3.79 |
8x8 | EGHT | May 17, 2024 | 2.76 | +2.99 |
908 Devices | MASS | May 17, 2024 | 6.85 | -0.44 |
99 Acquisition Group | NNAGU | May 17, 2024 | 10.60 | -3.37 |
99 Acquisition Group | NNAG | May 17, 2024 | 10.46 | +0.10 |
9F ADR | JFU | May 17, 2024 | 3.35 | +7.37 |
A SPAC I Acquisition Unit | ASCAU | May 17, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | May 17, 2024 | 11.14 | +0.09 |
A-Mark Precious Metals | AMRK | May 17, 2024 | 38.77 | +4.53 |
a.k.a Brands | AKA | May 17, 2024 | 26.17 | -0.15 |
A.O Smith | AOS | May 17, 2024 | 85.68 | +0.37 |
A10 Networks | ATEN | May 17, 2024 | 16.18 | +0.43 |
A2Z Smart Technologies | AZ | May 17, 2024 | 0.41 | -1.55 |
AAA - A Rated Corporate Bond Ishares | QLTA | May 17, 2024 | 46.88 | -0.21 |
Aadi Bioscience | AADI | May 17, 2024 | 1.91 | -0.26 |
AAON | AAON | May 17, 2024 | 74.88 | +0.03 |
AAR | AIR | May 17, 2024 | 71.24 | -1.19 |
Abacus Life | ABL | May 17, 2024 | 11.50 | -1.20 |
Abbott Laboratories | ABT | May 17, 2024 | 104.09 | -0.74 |
AbbVie | ABBV | May 17, 2024 | 166.42 | +1.26 |
AbCellera Biologics | ABCL | May 17, 2024 | 3.64 | -3.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.